The vision of the RCMI program at Xavier is aligned with the university's vision to achieve recognition for our national prominence in research, particularly in the areas of cancer and health disparities research.
To build on and enhance faculty competitiveness at Xavier University's strengths in cancer and health disparities research in a manner that will not only lead to exciting new discoveries, but also intensify our efforts to translate the results of these activities to the benefit of the public, particularly the underserved.
The RCMI program has selected 5 specific goals to increase research capacity:
-
To Strengthen Internal and External Collaborations and Partnerships Particularly those that Promote Health Disparities and Translational Research.
-
To Enhance Critical Core Laboratory Services.
-
To Increase Xavier's Pool of Competitive and Productive Cancer and Health Disparities Researchers who Participate in the "Translational Research Pipeline".
-
To Establish a New Pilot Project Program (PPP) for Cancer/Health Disparities Research.
-
To Provide Targeted Administrative Services in Support of RCMI Investigators.
Xavier's RCMI funding is provided by the National Institutes of Health (NIH) through the National Institute on Minority Health and Health Disparities (NIMHD) grant #U54MD007595, which provides laboratory scientists and clinical researchers with the tools and training they need to understand, detect, treat and prevent a wide range of diseases. NIMHD supports all aspects of clinical and translational research, connecting researchers, patients and communities across the nation. This support enables discoveries made at a molecular and cellular level to move to animal-based studies, and then to patient-oriented clinical research, ultimately leading to improved patient care. NIMHD convenes innovative research teams and equips them with essential tools and critical resources needed to tackle the nation's complex health problems.